FDA recall D-0235-2016

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · Class III · drug

Product

Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufactured by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. Mylan. NDC: 51079-090-20.

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification for impurities.

Distribution

US Nationwide including Puerto Rico

Key facts

Status
Terminated
Initiation date
2015-11-02
Report date
2015-11-25
Termination date
2016-12-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Rockford, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0235-2016